Ann: Presentation at NWR Virtual Healthcare Conference, page-8

"Hilarious she’s harping on about the nature cancer magazine from pre ipo like 6 years ago"

There is absolutely nothing wrong with this , as like most R&D ...it is an evolution and progression from key "foundation" observations or results .

Whilst no one is happy about the share price etc etc ..... the progression continues ....and recent results announced can only be described as exciting . ...and that's a very important fact !!! and I suspect these results will not go un noticed .

Whilst there has been huge dilution due to the SOI ... the market cap is " miniscule " compared with possible value proposition that could be crystalized .

Frankly I wouldn't be surprised to see a sharp revaluation 2 - 10 times from here .

Dunno when ... but IF it happens ...... etc etc

GLTAH